Bold 250 - Onyx Pharma

Boldenone undecylenate originated from early testosterone modifications developed by Ciba in the postwar era. Patented in 1949 and briefly sold as Parenabol in the 1960s, it was intended for clinical use in treating catabolic states. Human production ended by the 1970s, but Squibb soon reintroduced the compound as Equipoise for veterinary application, particularly in horses. Its long-lasting undecylenate ester and moderate anabolic activity contributed to its enduring use in non-clinical performance enhancement.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Bold 250 by Onyx Pharma, consult with your doctor or healthcare professional.